PRILOCAINE

UNII: 046O35D44R
Formula: C13H20N2O
Preferred Substance Name: PRILOCAINE
InChIKey: MVFGUOIZUNYYSO-UHFFFAOYSA-N

721-50-6
211-957-0
(+/-)-N-(2-PROPYLAMINOPROPIONYL)-2-TOLUIDINE
(+/-)-PRILOCAINE
2-METHYL-.ALPHA.-PROPYLAMINOPROPIONANILIDE
ASTRA-1512
ASTRA-1515
DL-(+/-)-PRILOCAINE
EMLA COMPONENT PRILOCAINE
FORTACIN COMPONENT PRILOCAINE
N-(2,6-DIMETHYLPHENYL)-2-(PROPYLAMINO)PROPANAMIDE
N-(2-METHYLPHENYL)-2-(PROPYLAMINO)PROPANAMIDE
NSC-40027
O-METHYL-2-PROPYLAMINOPROPIONANILIDE
O-PROPIONOTOLUIDIDE, 2-(PROPYLAMINO)-
ORAQIX COMPONENT PRILOCAINE
PRILOCAINE [EP MONOGRAPH]
PRILOCAINE [HSDB]
PRILOCAINE [INN]
PRILOCAINE [MART.]
PRILOCAINE [MI]
PRILOCAINE [ORANGE BOOK]
PRILOCAINE [USAN]
PRILOCAINE [USP MONOGRAPH]
PRILOCAINE [USP-RS]
PRILOCAINE [VANDF]
PRILOCAINE [WHO-DD]
PRILOCAINE COMPONENT OF EMLA
PRILOCAINE COMPONENT OF FORTACIN
PRILOCAINE COMPONENT OF ORAQIX
PROPANAMIDE, N-(2-METHYLPHENYL)-2-(PROPYLAMINO)-
PROPITOCAINE
PROPITOCAINE [JAN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

Powered by